2Vetter RJ.Regulations for radioiodine therapy in the United States:current status and the process of change[].Thyroid.1997
二级参考文献5
1Leonard RC, Edward BS, Phyllis JK, et al.Therapeutic 131Ⅰ in outpatients: a simplified method conforming to the code of federal regulations,title 10, part 35.75. J Nucl Med, 2000, 41:1868-1875.
2US Nuclear Regulatory Commission. 10 CFR part 35.75: release of individuals containing unsealed byproduct material or implants containing byproduct material. Washington, DC: US Government Printing Office, 2000.
3National Council on Radiation Protection and Measurements. Precaution in the management of patients who have received therapeutic amounts of radionuclides. NCRP Report No. 37. Washington, DC: NCRP, 1970.
5Al-Hai AN, Lagard CS, Lobriguito AM. Patient parame- ters and other radiation safety issues in 131I therapy for thyroid cancer treatment [J]. Health Phys, 2007,93 (6) : 656-666.
6International commission on radiological protention. Re- lease of patients after therapy with unsealed radionuclides [J]. Ann ICRP, 2004,34 (2) : 1-79.
